1. Home
  2. BSET vs IPHA Comparison

BSET vs IPHA Comparison

Compare BSET & IPHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bassett Furniture Industries Incorporated

BSET

Bassett Furniture Industries Incorporated

HOLD

Current Price

$18.96

Market Cap

169.9M

ML Signal

HOLD

Logo Innate Pharma S.A. ADS

IPHA

Innate Pharma S.A. ADS

HOLD

Current Price

$2.13

Market Cap

165.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BSET
IPHA
Founded
1902
1999
Country
United States
France
Employees
N/A
N/A
Industry
Home Furnishings
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
169.9M
165.3M
IPO Year
1995
2014

Fundamental Metrics

Financial Performance
Metric
BSET
IPHA
Price
$18.96
$2.13
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$5.75
AVG Volume (30 Days)
27.9K
167.1K
Earning Date
04-01-2026
03-26-2026
Dividend Yield
5.49%
N/A
EPS Growth
163.06
N/A
EPS
0.37
N/A
Revenue
$456,855,000.00
N/A
Revenue This Year
$1.72
$180.36
Revenue Next Year
$3.78
N/A
P/E Ratio
$50.97
N/A
Revenue Growth
0.96
N/A
52 Week Low
$13.17
$1.18
52 Week High
$22.26
$2.71

Technical Indicators

Market Signals
Indicator
BSET
IPHA
Relative Strength Index (RSI) 43.02 55.87
Support Level $18.78 $1.68
Resistance Level $20.81 $2.58
Average True Range (ATR) 0.66 0.14
MACD -0.19 0.01
Stochastic Oscillator 1.98 47.80

Price Performance

Historical Comparison
BSET
IPHA

About BSET Bassett Furniture Industries Incorporated

Bassett Furniture Industries Inc is a manufacturer, marketer, and retailer of home furnishings products in the United States. It operates through the following segments: The Wholesale segment focuses on the design, manufacture, sourcing, sale, and distribution of furniture products, the Retail segment which consists of company-owned stores, and the Corporate and others segment. Majority of revenue is from Wholesale sales of furniture and accessories.

About IPHA Innate Pharma S.A. ADS

Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. The company's approach includes therapeutic modalities such as monoclonal antibodies, multispecific NK cell engagers through its ANKET platform, and antibody-drug conjugates (ADC). Its portfolio includes lacutamab, which is being studied for cutaneous T-cell lymphomas and peripheral T-cell lymphomas, and monalizumab, which is being developed in collaboration with AstraZeneca for non-small cell lung cancer. The company's revenue mainly consists of revenues from collaboration and licensing agreements and government financing for research expenditure in the form of research tax credits, as well as other grants.

Share on Social Networks: